TrialBioMed research international2018

Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma.

Qi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.